Bench‐to‐bedside translation of chimeric antigen receptor (CAR) T cells using a multiscale systems pharmacokinetic‐pharmacodynamic model: A case study with anti‐BCMA CAR‐T

Despite tremendous success of chimeric antigen receptor (CAR) T cell therapy in clinical oncology, the dose‐exposure‐response relationship of CAR‐T cells in patients is poorly understood. Moreover, the key drug‐specific and system‐specific determinants leading to favorable clinical outcomes are also...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Aman P., Chen, Wenbo, Zheng, Xirong, Mody, Hardik, Carpenter, Thomas J., Zong, Alice, Heald, Donald L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099446/
https://www.ncbi.nlm.nih.gov/pubmed/33565700
http://dx.doi.org/10.1002/psp4.12598

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099446/
https://www.ncbi.nlm.nih.gov/pubmed/33565700
http://dx.doi.org/10.1002/psp4.12598

Ejemplares similares